세포배양 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2025-2033년)

Cell Culture Market Summary

The global cell culture market size was estimated at USD 20.47 billion in 2024 and is projected to reach USD 53.17 billion by 2033, growing at a CAGR of 11.21% from 2025 to 2033. The industry is primarily driven by the rising demand for biopharmaceuticals, increasing adoption of cell-based assays in drug discovery, and advancements in cell culture technologies.

Expansion in the Scope of Cell Culture Technology

The growing range and adaptability of cell culture technology across numerous scientific and industrial domains are driving the market's strong expansion. Cell culture was once limited to basic biological research, but it is now essential to various fields, including toxicology testing, biopharmaceutical manufacturing, regenerative medicine, and vaccine development. Experiments are more efficient and reproducible due to technology's ability to control cellular environments precisely. Researchers can produce cell-based products with higher yields and purities due to advancements in serum-free and chemically defined media, which encourage their use in both academic and commercial settings.

In addition, the ability of cell culture to replicate physiological conditions has been greatly expanded by the incorporation of 3D culture systems, organoids, and microfluidic "organ-on-a-chip" platforms. By facilitating more predictive preclinical testing and the development of tailored therapeutic approaches, these advancements facilitate the transition to personalized medicine.

Global Cell Culture Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels, and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cell culture market report on the basis of product, application, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Consumables
  • Sera
  • Fetal Bovine Serum
  • Other
  • Reagents
  • Albumin
  • Others
  • Media
  • Serum-free Media
  • CHO Media
  • HEK 293 Media
  • BHK Medium
  • Vero Medium
  • Other Serum-free Media
  • Classical Media
  • Stem Cell Culture Media
  • Chemically Defined Media
  • Specialty Media
  • Other Cell Culture Media
• Instruments
  • Culture Systems
  • Incubators
  • Centrifuges
  • Cryostorage Equipment
  • Biosafety Equipment
  • Pipetting Instruments
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Production
  • Monoclonal Antibodies
  • Vaccines Production
  • Other Therapeutic Proteins
• Drug Development
• Diagnostics
• Tissue Culture & Engineering
• Cell and Gene Therapy
• Toxicity Testing
• Other Applications
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Product Segment
    • 1.1.1.2. Application Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objective
  • 1.4.1. Objective 1
  • 1.4.2. Objective2
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Expansion in the scope of cell culture technology
    • 3.2.1.2. Rising demand for biopharmaceuticals, artificial organs, & vaccine production
    • 3.2.1.3. Growth in demand for serum-free, specialty, and customized media
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent process control in cell culture techniques
    • 3.2.2.2. Scalability issues with culturing methods
    • 3.2.2.3. Ethical concerns regarding use of animals
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Cell Culture Market: Product Movement Analysis
• 4.3. Global Cell Culture Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Consumables
  • 4.4.1. Global Consumables Market, 2021 - 2033 (USD Million)
  • 4.4.2. Media
    • 4.4.2.1. Global media market, 2021 - 2033 (USD Million)
    • 4.4.2.2. Serum-free media
      • 4.4.2.2.1. Global serum-free media market, 2021 - 2033 (USD Million)
      • 4.4.2.2.2. CHO media
        • 4.4.2.2.2.1. Global CHO media market, 2021 - 2033 (USD Million)
      • 4.4.2.2.3. BHK medium
        • 4.4.2.2.3.1. Global BHK medium market, 2021 - 2033 (USD Million)
      • 4.4.2.2.4. Vero medium
        • 4.4.2.2.4.1. Global Vero medium market, 2021 - 2033 (USD Million)
      • 4.4.2.2.5. HEK 293 Media
        • 4.4.2.2.5.1. Global HEK 293 media market, 2021 - 2033 (USD Million)
      • 4.4.2.2.6. Other serum-free media
        • 4.4.2.2.6.1. Global other serum-free media market, 2021 - 2033 (USD Million)
    • 4.4.2.3. Classical media
      • 4.4.2.3.1. Global classical media market, 2021 - 2033 (USD Million)
    • 4.4.2.4. Stem cell culture media
      • 4.4.2.4.1. Global stem cell culture media market, 2021 - 2033 (USD Million)
    • 4.4.2.5. Specialty media
      • 4.4.2.5.1. Global specialty media market, 2021 - 2033 (USD Million)
    • 4.4.2.6. Chemically defined media
      • 4.4.2.6.1. Global chemically defined media market, 2021 - 2033 (USD Million)
    • 4.4.2.7. Other cell culture media
      • 4.4.2.7.1. Global other cell culture media market, 2021 - 2033 (USD Million)
  • 4.4.3. Sera
    • 4.4.3.1. Global sera market, 2021 - 2033 (USD Million)
    • 4.4.3.2. Fetal bovine serum
      • 4.4.3.2.1. Global fetal bovine serum market, 2021 - 2033 (USD Million)
    • 4.4.3.3. Others
      • 4.4.3.3.1. Global others market, 2021 - 2033 (USD Million)
  • 4.4.4. Reagents
    • 4.4.4.1. Global reagents market, 2021 - 2033 (USD Million)
    • 4.4.4.2. Albumin
      • 4.4.4.2.1. Global albumin market, 2021 - 2033 (USD Million)
    • 4.4.4.3. Others
      • 4.4.4.3.1. Global others market, 2021 - 2033 (USD Million)
• 4.5. Instruments
  • 4.5.1. Global instruments market, 2021 - 2033 (USD Million)
  • 4.5.2. Culture systems
    • 4.5.2.1. Global culture systems market, 2021 - 2033 (USD Million)
  • 4.5.3. Incubators
    • 4.5.3.1. Global incubators market, 2021 - 2033 (USD Million)
  • 4.5.4. Centrifuges
    • 4.5.4.1. Global centrifuges market, 2021 - 2033 (USD Million)
  • 4.5.5. Cryostorage equipment
    • 4.5.5.1. Global cryostorage equipment market, 2021 - 2033 (USD Million)
  • 4.5.6. Biosafety equipment
    • 4.5.6.1. Global biosafety equipment market, 2021 - 2033 (USD Million)
  • 4.5.7. Pipetting instruments
    • 4.5.7.1. Global pipetting instruments market, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Cell Culture Market: Application Movement Analysis
• 5.3. Global Cell Culture Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Biopharmaceutical Production
  • 5.4.1. Global Biopharmaceutical Production Market, 2021 - 2033 (USD Million)
  • 5.4.2. Monoclonal antibodies
    • 5.4.2.1. Monoclonal antibodies market, 2021 - 2033 (USD Million)
  • 5.4.3. Vaccines production
    • 5.4.3.1. Global vaccines production market, 2021 - 2033 (USD Million)
  • 5.4.4. Other therapeutic proteins
    • 5.4.4.1. Global other therapeutic proteins market, 2021 - 2033 (USD Million)
• 5.5. Drug Development
  • 5.5.1. Global drug development market, 2021 - 2033 (USD Million)
• 5.6. Diagnostics
  • 5.6.1. Global diagnostics market, 2021 - 2033 (USD Million)
• 5.7. Tissue Culture & Engineering
  • 5.7.1. Global tissue culture & engineering, 2021 - 2033 (USD Million)
• 5.8. Cell & Gene Therapy
  • 5.8.1. Global cell and gene therapy market, 2021 - 2033 (USD Million)
• 5.9. Toxicity Testing
  • 5.9.1. Global toxicity testing market, 2021 - 2033 (USD Million)
• 5.10. Other Applications
  • 5.10.1. Global other applications market, 2021 - 2033 (USD Million)

Chapter 6. Regional Business Analysis

• 6.1. Cell Culture Market Share By Region, 2024 & 2033
• 6.2. North America
  • 6.2.1. North America Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. Key Country Dynamics
    • 6.2.2.2. Competitive Scenario
    • 6.2.2.3. Regulatory Framework
    • 6.2.2.4. U.S. Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. Competitive Scenario
    • 6.2.3.3. Regulatory Framework
    • 6.2.3.4. Canada Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Key Country Dynamics
    • 6.2.4.2. Competitive Scenario
    • 6.2.4.3. Regulatory Framework
    • 6.2.4.4. Mexico Cell Culture Market, 2021 - 2033 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. UK Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. Germany Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Competitive Scenario
    • 6.3.4.3. Regulatory Framework
    • 6.3.4.4. France Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Key Country Dynamics
    • 6.3.5.2. Competitive Scenario
    • 6.3.5.3. Regulatory Framework
    • 6.3.5.4. Italy Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Key Country Dynamics
    • 6.3.6.2. Competitive Scenario
    • 6.3.6.3. Regulatory Framework
    • 6.3.6.4. Spain Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Key Country Dynamics
    • 6.3.7.2. Competitive Scenario
    • 6.3.7.3. Regulatory Framework
    • 6.3.7.4. Denmark Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Key Country Dynamics
    • 6.3.8.2. Competitive Scenario
    • 6.3.8.3. Regulatory Framework
    • 6.3.8.4. Sweden Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Key Country Dynamics
    • 6.3.9.2. Competitive Scenario
    • 6.3.9.3. Regulatory Framework
    • 6.3.9.4. Norway Cell Culture Market, 2021 - 2033 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. Japan Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. China Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. India Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.4.5. Australia
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Competitive Scenario
    • 6.4.5.3. Regulatory Framework
    • 6.4.5.4. Australia Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.4.6. Thailand
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Competitive Scenario
    • 6.4.6.3. Regulatory Framework
    • 6.4.6.4. Thailand Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.4.7. South Korea
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Competitive Scenario
    • 6.4.7.3. Regulatory Framework
    • 6.4.7.4. South Korea Cell Culture Market, 2021 - 2033 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Brazil Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Argentina Cell Culture Market, 2021 - 2033 (USD Million)
• 6.6. MEA
  • 6.6.1. MEA Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. South Africa Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Saudi Arabia Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. UAE Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Kuwait Cell Culture Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Strategy Mapping
• 7.3. Company Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Sartorius AG
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Danaher
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Merck KGaA
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Thermo Fisher Scientific, Inc.
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Corning Inc.
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Avantor Inc.
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. BD
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. Eppendorf SE
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Bio-Techne
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. PromoCell GmbH
    • 7.4.10.1. Overview
    • 7.4.10.2. Product Benchmarking
    • 7.4.10.3. Strategic Initiatives